| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017530 |
| Receipt No. | R000020146 |
| Official scientific title of the study | An exploratory trial about the efficacy of lactobacillus A and substance B on endometriosis |
| Date of disclosure of the study information | 2015/05/31 |
| Last modified on | 2017/11/12 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | An exploratory trial about the efficacy of lactobacillus A and substance B on endometriosis | |
| Title of the study (Brief title) | An exploratory trial about the efficacy of lactobacillus A and substance B on endometriosis | |
| Region |
|
|
| Condition | ||
| Condition | endometriosis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect on endometriosis and safety of Lactobacillus A and substance B. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Pain is assessed with VAS.
The average score of menstrual pain when combination drug is used is compared with that of menstrual pain when single drug is used |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | combination drug is administarated for 3 months | |
| Interventions/Control_2 | single drug is administarated for 3 months | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1 patients who obtained the diagnosis of endometriosis
1-1 Past history of operation for endometriosis. diagnosed pathologically or surgical findings with the observation at the operation. 1-2 The patient diagnosed endometriosis by an internal exam or ultrasound exam 2 The menstrual cycle is within 25-31days low dose EP is unconcerned. 3 Use at least one dose of painkiller dualing the time of menstrual periods. |
|||
| Key exclusion criteria | 1) have severe asthma or allergy to multiple drugs
2) has diarrhea by uptake of dairy goods 3) have past history of allergy to dairy products 4) cervical cytology worse than class 2 5) have carcinoma 6) severe hepatic or renal damage or have past history of cardiac infarct 7) past history of hepatitis 8) severe anemia 9) appropriate judged by responsible doctor |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | TAKAMURA MASASHI |
| Organization | University of Tokyo |
| Division name | Obstetrics and Gynecology |
| Address | 7-3-1 Hongo Bunkyo Tokyo, Japan |
| TEL | 03-3815-5411 |
| takamura-tky@umin.ac.jp | |
| Public contact | |
| Name of contact person | TAKAMURA MASASHI |
| Organization | University of Tokyo |
| Division name | Obstetrics and Gynecology |
| Address | 7-3-1 Hongo Bunkyo Tokyo, Japan |
| TEL | 03-3815-5411 |
| Homepage URL | |
| takamura-tky@umin.ac.jp | |
| Sponsor | |
| Institute | The University of Tokyo Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Meiji co., Ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京大学病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020146 |